Background: Many data highlight the benefits of the Mediterranean diet and its main lipid component, extra-virgin olive oil (EVOO). EVOO contains many phenolic compounds that have been found effective against several aging-and lifestyle-related diseases, including neurodegeneration. Oleuropein, a phenolic secoiroid glycoside, is the main polyphenol in the olive oil. It has been reported that the aglycone form of Oleuropein (OleA) interferes in vitro and in vivo with amyloid aggregation of a number of proteins/peptides involved in amyloid, particularly neurodegenerative, diseases avoiding the growth of toxic oligomers and displaying protection against cognitive deterioration.
Introduction
Systemic amyloidosis include severe, potentially fatal, diseases characterized by multiorgan deposition of insoluble fibrillar polymeric material grown from misfolded proteins. The rarity and the variable involvement of different organs and tissues are often responsible for missed or delayed diagnosis, which makes amyloid diseases a severe clinical challenge. A large wealth of data support the idea that the pathological features of systemic amyloidosis stem primarily from the concurrent presence of amyloid deposits arising from the ordered polymerization of a number of specific proteins and their circulating amyloidogenic precursors [1, 2] . Consequently, at the present, the research for new compounds, either synthetic, natural or derived from natural molecular scaffolds, able to interfere with the aggregation of proteins involved in amyloid diseases, is considered a rewarding strategy to develop new therapeutic strategies. Plant polyphenols have been extensively studied for their multiple biological activities, including anti-oxidant, anti-inflammatory, antidiabetic, anti-aggregation and anti-cancer power [3] . These effects have raised the interest in plant polyphenols for their possible use, among others, to prevent tissue deposits of amyloid aggregates and to contrast pathological tissue reactions to the latter [4] . In particular, it has repeatedly been reported that the Mediterranean diet (MD), naturally enriched in plant polyphenols such as resveratrol (contained in red wine) and oleuropein (the main polyphenol in the olive leaves, drupes and oil) and many others is effective against age-related deterioration and improves agingassociated degenerative diseases and neurological deficits [5] .
The glycated oleuropein molecule consists of the polyphenol hydroxytyrosol (4-(2-hydroxyethyl)benzene-1,2-diol) esterified to both elenolic acid and glucose. Recent research on oleuropein aglycone (OleA), a metabolic product resulting from the action of endogenous β-glucosidases, has focused on its general ability to remodel and inactivate toxic amyloid oligomers [6] . In particular, OleA interferes with amyloid aggregation of human islet amyloid polypeptide (hIAPP) [7] , Aβ42 [8] and transthyretin [9] skipping the appearance of toxic oligomers and/or favouring aggregation into off-pathway aggregates. The behaviour of OleA matches that of many other polyphenols, even though the mechanism of their anti-aggregation effect can differ in different molecules [10] . In vivo studies have confirmed that OleA protects against Aβ42 aggregation and plaque formation in tissue. These studies were carried out using transgenic animal models of Aβ42 aggregation and plaque deposition such as C. elegans [11] and the TgCRND8 mouse model [12] . In particular, in the latter, dietary supplementation of OleA strongly improved the cognitive performance with respect to untreated littermates. Such a positive effect matched reduced Aβ42 levels and plaque deposits in the animal brain together with reduced inflammatory response, increased synaptic function (LTP), and neurogenesis, microglia migration to the plaques for phagocytosis and an intense activation of the autophagic flux. These biochemical modifications in OleA-fed mice were traced back, at least in part, to the induction of epigenetic modifications [13] . Finally, a recent study reports that OleA is able to locate at the surface of the cell membrane interacting specifically with negatively charged phospholipids of synthetic lipid bilayers [14] , suggesting its effective ability to interact with the cell membrane. This finding is of interest considering that the interaction of OleA with the cell membrane can either interfere with bilayerbinding properties of amyloid species and/or increase the local concentration of the polyphenol itself; the latter can be a particularly relevant effect considering the low amounts of polyphenol intake with a normal diet and its limited bioavailability.
An increasing body of data considers amyloid cytotoxicity as the overall result of a complex interplay between the biochemical and biophysical properties of both amyloid aggregates and the cell membrane they interact with [15] [16] [17] [18] . The biochemical, biophysical and mechanistic aspects of this interaction are widely considered an early event of amyloid cytotoxicity and have been the focus of intense research in recent years [15] [16] [17] [18] [19] . However, the development of therapeutic strategies has been largely directed to search substances able to interfere with the process of amyloid aggregation [19] , whereas the investigation of molecules able to interfere with membrane activity and lipid-binding properties of amyloid species has been addressed only marginally.
In this study, we extended and implemented our previous data on the effects of OleA against the first described naturally occurring structural variant, Asp76Asn (D76N), of human β2-microglobulin (b2m) [20] [21] [22] , a 99 residue protein subunit of the MHC-I produced by all nucleated cells as a 119 residue precursor. b2m displays a β-sandwich fold typical of the immunoglobulin superfamily and contains seven β-strands. Normally, once released from the quaternary structure of MHC-I, b2m is cleared from the circulation in the proximal tubules of the kidneys. However, in patients undergoing long-term dialysis, the serum concentration of b2m rises from normal levels (1-2 mg/L) to as much as 50-70 mg/L. Such a dramatic increase of concentration is believed to be the main cause of b2m aggregation in these patients. [23] . The pathogenic naturally occurring D76N variant is aggressively fibrillogenic in vitro, forcing a re-evaluation of previously hypothesized mechanisms of b2m fibrillogenesis. In contrast to patients with dialysis-related amyloidosis, all members of the family carrying such mutation had normal circulating concentrations of b2m and normal renal function. Despite the misfolding propensity of the D76N variant and the essential contribution of b2m to the structure of the MHC-I complex, none of the heterozygote subjects displayed clinical evidence of immunodeficiency [20] . On the contrary, extensive amyloid deposits of D76N b2m were found in the spleen, liver, heart, salivary glands, and nerves of the homozygotes where, in the absence of adequate therapy, the disease resulted in a fatal outcome [20] .
We have recently reported that amyloid aggregates of D76N b2m interact specifically with the plasma membrane of the exposed cells at the level of GM1, a major lipid rafts component, and this findings was assumed to at the basis, at least in part, of their toxic effects [21] . These data led us to hypothesize that, particularly for D76N b2m amyloidosis, inhibiting aggregate-membrane interaction could be a very important way to protect cells against aggregate cytotoxicity thus reducing at least some symptoms of the disease. Accordingly, we extended our previous findings in SH-SY5Y cells by investigating the ability of OleA to interfere with D76N b2m aggregation and aggregate cytotoxicity. We found that OleA reduces D76N b2m cytotoxicity (i.) by favoring the appearance of non-toxic aggregates; (ii.) by decreasing aggregate interaction with the plasma membrane at GM1-enriched sites; (iii.) by enhancing cell resistance against the toxic effects of the aggregates. Our data offer the possibility to validate and optimize the use of OleA to rationally design novel and promising pharmacological tools to be used for prevention and therapy of systemic amyloidosis.
2.Materials and Methods

2.1
In vitro aggregation of D76N b2m. D76N b2M was expressed and purified as previously reported [22] . The aggregation reaction was initiated starting from the freeze-dried protein. Briefly, the protein was dissolved in PBS (Sigma Aldrich, Saint Louis, MO, USA) and centrifuged for 5 min at 13200 × g. To achieve aggregation, the resulting supernatant was diluted to 20 µM concentration; and 300 µL of the solution was incubated at 37 °C in a 1.5 mL eppendorf tube lying in horizontal position under vigorous shaking. Protein aggregation in the presence of the polyphenol was performed at 1:3 protein:OleA molar ratio. All aggregate concentrations are referred to as monomer concentration.
Oleuropein deglycosylation.
Oleuropein glycoside was purchased from Extrasynthese (Genay, France) and deglycosylated by treatment with almond β-glycosidase (EC 3.2.1.21, Fluka, SigmaAldrich) as previously described [8] . Briefly, a 10 mM solution of oleuropein glycoside in 310 µl of 0.1 M sodium phosphate buffer, pH 7.0, was incubated with 8.9 I.U. of β-glucosidase overnight at room temperature. At the end of the incubation, the aglycone (OleA) was precipitated by centrifuging the reaction mixture at 13200 × g for 10 min. The precipitate was resuspended in dimethyl sulfoxide (DMSO) at 100 mM concentration and batched in aliquots kept frozen and protected from light. Complete oleuropein deglycosylation was confirmed by assaying the glucose released in the supernatant with the Glucose (HK) Assay kit (Sigma-Aldrich, Saint Louis, MO, USA). Each OleA stock was used within the same day once opened.
Dynamic Light scattering (DLS).
Size distribution analysis of D76N b2m aggregates was carried out at 25 °C using a Malvern Zetasizer Nano S DLS device (Malvern, Worcestershire, UK) on 20 µM protein samples aggregated in the presence or in the absence of OleA. Each sample was centrifuged at 13200 × g for 30 min at 4 °C to spin down large aggregates. Size distributions by intensity and total light-scattering intensity were determined in 10 acquisitions (cell position 4.2 cm, attenuator index 7) of 10 s each, over a period of 10 min. The reported data are the average of three independent measurements.
Intrinsic fluorescence measurements.
Intrinsic fluorescence Spectra of D76N b2m were collected at 295 nm excitation before and after adding OleA and the emission intensity was scanned in the 320-430 nm range. The fluorescence emission spectra were acquired using the Biotek Synergy 1H plate reader. To perform this experiment we analyzed D76N aggregates obtained in the absence or in the presence of OleA at different times points. We tested also different protein:OleA molar ratios by using OleA at 10 µM 2.5 Transmission electron microscopy. TEM analysis was carried out as previously reported [21] .
Briefly, 5.0 mL aliquots of D76N b2m were withdrawn from the aggregation mixture at different time intervals, loaded onto a formvar/carbon-coated 400 mesh nickel grids (Agar Scientific, Stansted, UK) and negatively stained with 2.0% (w/v) uranyl acetate (Sigma-Aldrich, Saint Louis, MO, USA). The grid was air-dried and examined using a JEM 1010 transmission electron microscope at 80 kV excitation voltage.
Congo Red Assay.
The assay was performed as previously described [25] taking into account that amyloid binding induces a characteristic shift from 490 nm to 540 nm in the Congo Red (CR) maximum absorbance [26] . In particular, D76N b2m (20 µM) aggregation was monitored in the presence or in the absence of 3×OleA. Either native D76N b2m and its aggregates were incubated with 5.0 mM sodium phosphate buffer, pH 7.0, containing 150 mM NaCl and 20 µM CR. The CR spectra were recorded in the 400-700 nm region using a Jasco V-630 spectrophotometer. Blank spectra were acquired for CR alone, in the presence or in the absence of OleA, and subtracted to sample spectra. We performed two types of some controls to asses the OleA interference on CR absorbance: i) OleA was added in the same time with CR on pre-formed aggregates, ii) OleA was added after D76N aggregates CR absorbance detection. 
Thioflavin
2.9
Cell culture and cell viability assay. SH-SY5Y cells were cultured at 37 °C in complete medium (50% HAM, 50% DMEM, 10% foetal bovine serum, 3.0 mM glutamine, 100 units/mL penicillin and 100 µg/mL streptomycin), in a humidified, 5.0% CO 2 incubator. All materials used for cell culture were from Sigma (Sigma Aldrich, Saint Louis, MO, USA). Samples containing aggregating D76N b2m were administered to the cells at a final concentration of 5.0 µM (monomeric protein concentration). The cytotoxicity of the different forms of D76N aggregates grown at different aggregation times was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma Aldrich, Saint Louis, MO, USA) reduction inhibition assay based on the protocol described for the first time by Mosmann [27] . In all MTT-experiments, the cells were plated and incubated for 48 h at a density of 10000 cells/well on 96-well plates in 100 µL culture medium. Then, the cells were treated for 24 h with D76N b2m aggregates (5.0 µM) grown in the absence or in the presence of OleA (15.0 µM). In some experiments, the cells were treated with 15.0 µM OleA for 24 h before exposure to the aggregates. After exposure, the cells were incubated for 2 h with 100 µL of DMEM without phenol red, containing 0.5 mg/mL MTT.
Then, 100 µL of cell lysis buffer (20% SDS, 50% N,N-dimethylformamide, pH 4,7) was added to each well and the samples were incubated at 37 °C for 2 h to allow complete cell lysis. Absorbance values of blue formazan were determined at 595 nm with an automatic plate reader (Bio-Rad, Hercules, Cal). The final absorption values were calculated by averaging three independent measurements of each sample after subtraction of the average of the blank solution (100 µL of MTT solution and 100 µL of lysis buffer consisting of 20% SDS in 50% N, N-dimethylformamide). All data were expressed as mean ± standard deviation. GM1 were prepared, dissolved in chloroform/methanol (2:1) according to the desired concentration and gently evaporated to dryness under a nitrogen flux. Sample aliquots were maintained overnight under vacuum and resuspended in Milli-Q water to form multilamellar vesicles (MLVs). MLVs were pre-sonicated at 60 °C for 1 h and then extruded 11 times through a polycarbonate membrane with 100 nm pores using a commercial extruder (Avanti Polar Lipids) at 60 °C. Lipid suspensions were cooled at room temperature and the so obtained suspensions of large unilamellar vesicles (LUVs) were diluted 10 folds in Milli-Q water. 40 µL of each suspension and 10 µL of a 10 mM CaCl 2 solution were deposited on a freshly cleaved mica substrate (1.0 cm × 1.0 cm). To get uniform bilayer coverage, the samples were incubated 15 min at 60 °C and then 10 min at room temperature. Then, the samples were kept at room temperature in a sealed chamber with 100% relative humidity. SLBs were gently rinsed three times with Milli-Q water to remove excess vesicles from the liquid sub phase before AFM measurements. In some experiments, SLBs, preformed as described in the previous paragraph, were exposed for 30 min to 15 µM OleA and then gently rinsed with MilliQ water to remove the excess of OleA from the solution.
Confocal
2.12 AFM imaging. AFM images were acquired by using a Nanowizard III (JPK Instruments, Germany) mounted on an Axio Observer D1 (Carl Zeiss, Germany) inverted optical microscope.
Sample topography before and after protein aggregate administrations [29] was determined by using 
Results
OleA interferes with amyloid aggregation of D76N b2m.
We initially used different biophysical techniques to investigate whether OleA interfered with the aggregation path of D76N b2m previously described (see under Materials and Methods) [22] . DLS analysis and negatively stained TEM showed that the general size and morphology of D76N b2m species obtained until 144 h of incubation under aggregating conditions were affected by the presence of the polyphenol (Fig. 1 A, B) . We chose the 144 h time since we previously showed that at that time the sample was populated almost exclusively by amyloid fibrils without any significant presence of precursors [21] . The DLS analysis showed a very broad size distribution of the OleAtreated protein samples with respect to that shown by the protein alone at the same conditions (Fig.1A) . TEM images taken at 24 and 96 h of D76N aggregation in the presence of the polyphenol showed the presence of evident short fibrils radially diverging from densely packed globular clusters, whereas very short fibrils embedded in a diffuse background of small rod-like aggregates were present in the absence of OleA (Fig.1B) . After 144 h of aggregation, long, straight and dispersed D76N b2m fibrils were seen, whereas in the presence of OleA the protein formed a dense meshwork of small fibril-like structures buried into amorphous aggregates (Fig.1B) . The D76N b2m aggregation in the presence or in the absence of the polyphenol was further investigated by the CR (Fig. 1C) and ThT (Fig. 1E) binding assays. The analysis revealed that the protein grown in the presence of OleA did bind CR, as confirmed by the presence of the peak at 570 nm, but to a lesser extent with respect to the protein alone (Fig. 1C) . The ThT fluorescence of D76N b2m increased and reached a plateau after 24 h (Fig.1E) , which is indicative of amyloid fibril formation. In this case, OleA did not alter the aggregation kinetics, even though it led to a slight decrease of ThT fluorescence. Interestingly, the ANS assay on D76N b2m aggregates (particularly those aged 24 h and 144 h) grown in the presence of OleA showed a significant reduction of ANS fluorescence, indicating a minor solvent exposure of hydrophobic clusters on aggregates surfaces (Fig.1D ). To observe a putative OleA interference with ThT, ANS and Congo Red binding, we performed control measurements where OleA was added to the preformed aggregates just before the experiments and we did not detect any interference (data not shown). (Fig. 2B) . A double reciprocal plot of the hyperbolic curve provided a dissociation constant (Kd) of 60 µM between EGCG and D76N b2m aggregates (Fig. 2B, inset) .
On biophysical set of experiments we had performed all necessary controls to confirm the results obtained when OleA is present during D76N aggregation process. In particular, OleA was added to the preformed aggregates (incubated for 24, 96, 144 hours) just before the experiments (D76N+OleA) and immediately after the CR, ANS and ThT signals recording.
In this control measurement we observed that OleA did not compete with ANS and ThT binding and fluorescence ( Fig. 1 insets D-E) . Instead the CR absorbance when OleA resulted be reduced, most evident on 144 h aggregates, but we did not observe a maximum peak shift, confirming that the OleA presences did not interfere on D76N amyloid aggregation (Fig 1 C) . We performed the same controls on D76N aggregates Intrinsic Fluorescence analysis, and as we has saw OleA did not quench the intrinsic fluorescence of aggregates when it was added after the reading (Fig. 2 insets C-F ). 
concentration. Dissociation constant (Kd) of 60 µM was calculated from a double-reciprocal plot of the saturation curve (Inset). C-F) Spectra of intrinsic fluorescence of D76N b2m obtained at different times B) 0 h, C) 24 h, D) 96 h, E) 144 h. To observe a putative
OleA protects against D76N b2m cytotoxicity.
It has been reported that the cytotoxicity of amyloidogenic species depends largely on their biophysical surface properties and that the latter influences their reactivity with the cell membrane [31] [32] [33] . Once shown that the presence of OleA during aggregation modulates some surface properties of D76N b2m aggregates, we checked by MTT assay whether the cytotoxicity of these samples was the same as that induced by the aggregates grown in the absence of the polyphenol.
We used human SH-SY5Y neuroblastoma cells considering that, D76N b2m amyloidosis involves also neural tissue [35] and that these cells had previously been shown to be sensitive to the toxicity of both wt-and D76N b2M aggregates [21, 34] . We found that D76N b2M aggregates grown for 96 h, 120 h or 144 h were more significantly cytotoxic than those aged 24 h (Fig 3A) , confirming previous data [21] . However, the presence of OleA during protein aggregation affected aggregate toxicity; in fact, we observed a reduction of cytotoxicity from 27.27% ± 11.65% to 16.93% ± 8.7%
for samples aggregated 96 h, from 41.73% ± 18.21% to 26% ± 12% for samples aggregated 120 h and, more significantly, from 43.84 ± 10.11% to 5.9 ± 13.37 % for 144 h-aged aggregates (Fig. 3A) .
These data also indicate that the extent of both aggregate toxicity and cytoprotection by the polyphenol increase as far as the aggregation time is prolonged. Moreover, no toxicity was observed when OleA and D76N b2M aggregates were added at the same time to the cells (144h+OleA) or when the cells were pre-treated with OleA for 24 h prior to exposure to the aggregates (preOleA/144h) (Fig. 3B) , suggesting that the polyphenol does not disassemble preformed fibrils with oligomer leakage. Moreover, OleA protection to cells pre-treated for 24 h persisted even after cell washing with PBS for 30 min (OleA30'/144h) or 2 h (OleA2h/144h) before exposure to 144 haged aggregates (Fig. 3B) . In summary, the presence of OleA substantially reduced the toxicity of D76N b2m aggregates in different experimental settings: i) presence of OleA during protein aggregation; ii) cell pre-treatment with OleA before exposure to the aggregates; and iii) cell treatment with OleA and D76N b2M aggregates at the same time (Fig. 3B ). These data suggest that
OleA interferes not only with the surface aggregates properties but also with the cytotoxic effects of pre-formed aggregates and that OleA-treated cells are more resistant to the aggregates toxic insult.
To better investigate OleA cytoprotection, we used FRET analysis to study aggregate-membrane binding. In agreement with previous results [21] , we found that D76N b2m aggregates aged 96 h, GM1 ( Fig. 3C column 1,2) , a well-known site favouring peptide/protein aggregation [34] and amyloid interaction with the cell membrane [34] [35] [36] . When SH-SY5Y cells were treated with D76N b2m aggregates grown in the presence of OleA we observed a lower FRET signal ( Fig. 3C column   2 ). The same FRET signal reduction was detected on SH-SY5Y cells pre-treated with OleA and when the polyphenol was added with 144 h aggregates ( fig. 3D column 2 ). This finding indicates that the polyphenol interferes with aggregate binding to the membrane modifying the surface properties of either the aggregates and/or the cell membrane (Fig. 3D) . The reduced aggregate interaction with the cell membrane in the presence of OleA is likely to contribute to cell protection by the polyphenol. 
OleA affects the interaction of D76N b2m with synthetic lipid membranes
Once assessed that OleA interferes with aggregate binding to the cell membrane and that GM1 is involved in binding, we used GM1-enriched SLBs to better evaluate the effect of OleA on aggregate-membrane interaction using aggregates aged 144 h. SLBs formed on a mica substrate showed segregation of different lipid species in well distinct domains characterized by different levels of order (Fig. 4A) . At our conditions, DOPC assembly resulted in SLBs displaying domains with low level of order (L α ), while the higher level of order (L β ) corresponded to domains enriched in cholesterol, sphingomyelin and GM1, mimicking the lipid composition of membrane raft domains in the cell membrane. The calculated difference in thickness between L β and L α domains (∆Z) was 2.2±0.2 nm; this value, very reproducible for both untreated SLBs and OleA-treated SLBs (Fig. 4E,G) , agrees with previous data [37] and was monitored to evaluate structural perturbations induced by the interaction of D76N b2m with the bilayer. We found that 144 h-aged aggregates grown in the absence of OleA were accumulating on the GM1-enriched L β domains (Fig. 4B) . The presence of aggregates on the ordered phase domains increased the typical thickness of these domains. The height distribution analysis taken from the AFM images of SLBs before and after aggregate administration (Fig. 4E, 4F ) indicated that the peak at 2.2 nm, associated to the ordered domains, was replaced by a broader peak at higher height values induced by the accumulation of amyloid material (Fig.4E,F) , confirming previous results [20] . However, when the SLBs were exposed to D76N b2m aggregates grown in the presence of OleA, the amount of aggregates present on the GM1-enriched phase domains was strongly decreased (Fig.4C) and ∆Z was preserved (Fig.4G) . A similar reduction of protein interaction with SLBs was found when aggregates preformed in the absence of OleA were added to SLBs pretreated with OleA (see under Materials and Methods). In addition, in this case, although some aggregates accumulated onto L β domains, the SLBs morphology was essentially preserved (Fig.4D, H) . A detailed analysis performed on the SLBs before and after OleA treatment confirmed that both the morphology (Fig. 5 A,B ) and the elasticity (Fig.5 C-F despite unaltered amyloid deposits in the myocardium [38] . Usually, in the amyloid diseases, it is likely that the impairment of cell function is a direct consequence of the interaction between cellular components and protein aggregates. Although a conspicuous amount of data on cytotoxic effects of amyloid aggregates is presently available, an in depth experimentally-based description of the structural features of these assemblies and of the structure-toxicity link is still lacking. The general picture emerging from the findings available in the last few years describes amyloid cytotoxicity as a relative concept rather than an inherent property of amyloid aggregates; in fact, it appears to result from a complex interplay between structural and biophysical features of both the amyloid assemblies and the cell membrane they interact with which determines the final outcome in terms of cell suffering and death [16] . The importance of GM1 as a key binder of amyloid oligomers and aggregates has also been repeatedly reported [17, [39] [40] [41] [42] [43] .
To date, the research of therapeutic approaches against amyloid toxicity has focused on the inhibition of protein self-assembly and the enhancement of aggregate clearance. In this context, current research aims to identify and describe molecules suitable to counteract protein misfolding, to hinder the appearance of toxic species in the aggregation path and/or to favor the growth of nontoxic assemblies, as well as to interfere with the interaction of the aggregates with the cell membrane and to foster cell resistance against aggregate toxicity. The search for treatments able to reinforce the cell defenses against amyloid cytotoxicity (including those active to maintain correct proteostasis, such as protein synthesis, the ubiquitin-proteasome and autophagy-lysosome pathways), is also actively pursued. Many natural or synthetic molecules that possess some of these properties have been described; among the latter, increasing interest is reserved to plant polyphenols found in several foods particularly enriched in the Mediterranean diet [44] . Resveratrol, curcumin, epigallocathechin-3-gallate (EGCG), quercetin, oleuropein aglycone (OleA) and hydroxytyrosol have been and are being widely studied not only for their well-known antioxidant power but also for their ability to relieve some symptoms of a number of aging-associated degenerative diseases including cancer and neurodegeneration [45] . These studies feature plant polyphenols or their molecular scaffolds as promising chemical tools useful to prevent, to delay and/or to treat many clinical symptoms of these diseases for which, in most cases, an effective therapy is still lacking.
This study adds to, and extend, a preceding one [21] supported by recent data indicating that OleA interacts with, and penetrates within, the bilayer in synthetic lipid membranes with different specific locations and interactions depending on membrane lipid composition [13] . It also agrees with the general view reported above which describes amyloid interaction with the cell membrane and cytotoxicity as the result of a complex interplay between aggregates and membrane physical and biochemical properties [16, 46] . We found similar data in OleA-treated cells. In fact, OleA protection to cells pre-treated for 24 h persisted even after cell washing with PBS for 30 min or 2 h before exposure to D76N aggregates.
The latter finding suggests OleA persistence within the cell membrane or inside the cytoplasm resulting in biochemical effects making the cell protected against aggregate injury or, alternatively, that the biochemical modifications following cell pre-treatment with OleA persists after polyphenol removal. Taking into account all these data, we suggest that OleA is able to reduce amyloid toxicity by modifying both the aggregate and the membrane biophysical properties; in fact, it did induce conformational and surface changes in D76N b2m aggregates but was also able to interact with the cell membrane with ensuing modification of membrane biochemical/biophysical properties, its biological activity and/or its ability to interact with toxic amyloids. The ability of OleA to affect cell membrane properties was confirmed by a recent investigation; the study reported that rosmarinic acid and black tea extract protect against permeabilization by Aβ, α-synuclein and tau-441 pre-fibrillar aggregates of both mitochondria isolated from neuronal SH-SY5Y cells and synthetic vesicles with lipid composition mimicking that of mitochondrial membranes [33, 34] .
Recent data suggest the existence of specific interactions between OleA and negatively charged phospholipids in synthetic and cell membranes [14] , where they have been reported to represent both nucleation and interaction sites of amyloids [35] . Our data confirm the importance of GM1, a main negatively charged lipid in the cell membrane, as a main site of interaction with D76N b2m fibrils; it also confirms that the presence of OleA in the protein aggregation solution or in the cell culture medium hinders such interaction and, possibly, enhances the cell defenses against the insult provided by the aggregates resulting in reduced cytotoxicity of fibrillar D76N b2m. These pieces of evidence lead to conclude that OleA is protective to our cellular model not only by modifying the structural and biophysical features of the aggregates grown in its presence; in fact, the interaction of OleA with the cell membrane and its reported location inside the bilayer might change both the physical properties and the biological activity of the latter by modulating its functional interaction with other biological molecules and by hindering amyloid binding, a key step of amyloid cytotoxicity.
Conclusion.
Our data add to, extend and confirm, many others obtained with different amyloidogenic proteins/peptides including amylin, Aβ peptides, transthyretin and wild type b2m, highlighting the interference of OleA with protein aggregation and aggregate cytotoxicity. Taken together, this body of coherent knowledge allows to further generalize the effects of OleA as a molecule with important protective effects against protein amyloid aggregation and some of the molecular and cellular derangements underlying many degenerative diseases with amyloid deposits.
